Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies, Tasly Pharmaceuticals Announce JV And Licensing Agreements

July 11 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * TASLY PHARMACEUTICALS AND MAUNA KEA TECHNOLOGIES ANNOUNCE
JOINT
VENTURE AND LICENSING AGREEMENTS
    * SUBJECT TO TRANSFERRING IP ASSETS AND CONTRIBUTING
LICENSES TO
JV, MAUNA KEA TO RECEIVE 44% EQUITY INTEREST IN JOINT VENTURE,
CASH PAYMENTS TOTALING $10 MILLION, AND CELLVIZIO PURCHASING
COMMITMENTS FOR 5 YEARS
    * JV ALSO TO ACQUIRE EXCLUSIVE WORLDWIDE RIGHTS TO DEVELOP
AND
COMMERCIALIZE CELLVIZIO IN FIELDS OF NEUROLOGY AND NEUROSURGERY

Source text for Eikon:  ID:nBwklCLTa 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mauna Kea Technologies SA

See all news